Evolution of HIV-1 Resistance to the Fusion Inhibitor C34-CXCR4 and Potential Fitness Costs in Consideration of a Phase 1 Clinical TrialGeorge J. Leslie,Beth Haggarty,Josephine Romano,Andrea P. O. Jordon,Jianbin Wang,Max W. Richardson,James L. Riley,Michael C. Holmes,Pablo Tebas,James HoxieMOLECULAR THERAPY(2017)引用 0|浏览34暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要